AKT1 and glioblastoma: To further confirm the key contribution of Erk or Akt signaling pathway activation to the proliferative function of KIF15 in GBM cells, we treated U87MG and T98G cells with Erk or Akt pathway inhibitor alone or combined with KIF15 siRNA.